ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,283,230 | -8.7% | 209,040 | -11.4% | 0.78% | +6.6% |
| Q2 2023 | $4,689,320 | +16.0% | 236,000 | 0.0% | 0.73% | +8.3% |
| Q1 2023 | $4,042,680 | -1.7% | 236,000 | +214.7% | 0.68% | +85.2% |
| Q4 2020 | $4,113,000 | -21.1% | 75,000 | -67.1% | 0.36% | -28.7% |
| Q3 2020 | $5,212,000 | -26.8% | 228,016 | -32.9% | 0.51% | -23.5% |
| Q2 2020 | $7,117,000 | +52.3% | 340,016 | +1.5% | 0.67% | +14.6% |
| Q1 2020 | $4,673,000 | -43.3% | 335,016 | -7.4% | 0.58% | -14.0% |
| Q4 2019 | $8,237,000 | +7.1% | 361,888 | -45.2% | 0.68% | -42.8% |
| Q3 2019 | $7,689,000 | +65.4% | 660,000 | +112.9% | 1.19% | +86.8% |
| Q2 2019 | $4,650,000 | -8.6% | 310,000 | +6.9% | 0.64% | +37.1% |
| Q1 2019 | $5,087,000 | +18.4% | 290,001 | 0.0% | 0.46% | -4.1% |
| Q4 2018 | $4,298,000 | +534.9% | 290,001 | +741.2% | 0.48% | +420.4% |
| Q2 2018 | $677,000 | -88.1% | 34,475 | -88.6% | 0.09% | -89.2% |
| Q1 2018 | $5,668,000 | – | 302,275 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |